Glucose B. Braun (Glucose Monohydrate)

Glucose B. Braun is used as an intravenous carbohydrate source in a variety of clinical situations where rapid energy provision or fluid balance is required.

• To supply glucose for energy during parenteral nutrition.
• As an osmotic agent in intravenous fluid therapy to maintain plasma volume.
• For correction of hypoglycemia when oral intake is not possible.
• As a diluent for compatible intravenous medications requiring a carbohydrate carrier.
• In perioperative settings to prevent intra‑operative hypoglycemia.
• To support glucose levels during prolonged fasting or critical illness.
• As part of electrolyte replacement solutions where glucose is required for cellular metabolism.

Glucose B. Braun, like other intravenous glucose solutions, may be associated with a range of adverse reactions that vary in frequency and severity.

Common

• Transient hyperglycemia when administered in excess.
• Local irritation or pain at the injection site.
• Mild electrolyte shifts, particularly sodium or potassium changes.
• Nausea or vomiting in susceptible individuals.
• Mild headache reported during rapid infusion.
• Temporary increase in serum osmolality.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Hypotension due to rapid osmotic shifts.
• Allergic or anaphylactoid reactions such as rash, urticaria, or bronchospasm.
• Metabolic acidosis in patients with impaired renal function.
• Fluid overload leading to pulmonary edema in patients with cardiac dysfunction.

When using Glucose B. Braun, clinicians should observe several precautions to minimize risks and ensure appropriate therapeutic outcomes.

• Verify patient’s blood glucose level before and after administration.
• Adjust infusion rate according to individual fluid and electrolyte status.
• Use aseptic technique to prevent contamination of the solution.
• Monitor for signs of hyperglycemia, especially in diabetic patients.
• Assess cardiac and renal function prior to large-volume administration.
• Avoid rapid bolus injection unless specifically indicated.
• Ensure compatibility with any co‑administered intravenous drugs before mixing.
• Document the total daily glucose load to avoid exceeding recommended caloric limits.

Glucose B. Braun may interact with certain medications or clinical conditions; awareness of these interactions helps guide safe administration.

Avoid

• Concurrent rapid infusion of hypertonic saline solutions, which can exacerbate osmotic shifts.
• Co‑administration with insulin infusions without appropriate glucose monitoring.

Use with caution

• Use with diuretics, as changes in fluid balance may affect glucose concentration.
• Caution when combined with beta‑blockers, which can mask hypoglycemia symptoms.
• Use with caution in patients receiving total parenteral nutrition, to avoid excessive carbohydrate load.
• Monitor closely when given with drugs that affect renal clearance, such as aminoglycosides.
• Consider adjusting the infusion rate when the patient is on corticosteroid therapy, which can increase glucose production.